Exploring value from the patient’s perspective between modern radiotherapy modalities for localised prostate cancer: beyond the abstract

There is a growing emphasis to deliver value-based cancer care. Often when value is measured the focus is only on costs and cure. However, when treatments are all equally curative, evaluating a patient’s full treatment experience becomes necessary. This premise led to our study question:  Are all modern radiotherapy treatments for localised prostate cancer equal from the patient’s point of view?